# PharmaCyte Biotech, Inc.: Form DEF 14A, filed Nov 25, 2022

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: DEF 14A
- Filed: 2022-11-25
- Accepted by EDGAR: Nov 25, 2022, 13:08 ET
- Period: 2022-12-28
- Accession: 0001683168-22-008032
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822008032/pharmacyte_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316822008032/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316822008032/pharmacyte_def14a.htm

Filed Nov 25, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-008032. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.